2022
DOI: 10.1093/brain/awac338
|View full text |Cite
|
Sign up to set email alerts
|

Seronegative autoimmune encephalitis: exploring the unknown

Abstract: This scientific commentary refers to ‘Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes’ by Lee et al. (https://doi.org/10.1093/brain/awac166).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 9 publications
0
2
0
Order By: Relevance
“…A recent study concluded that more aggressive treatment regimens in autoimmune encephalitis patients improved the 2-year outcome. However, a comment on this study suggested that first-line immunotherapy's effect was underestimated while second-line immunotherapy's effect was overestimated 26 , 43 . Based on our study, early treatment with anti-inflammatory drugs should be considered to minimize the risk of an unfavourable outcome in cases of CNS inflammatory diseases.…”
Section: Discussionmentioning
confidence: 74%
“…A recent study concluded that more aggressive treatment regimens in autoimmune encephalitis patients improved the 2-year outcome. However, a comment on this study suggested that first-line immunotherapy's effect was underestimated while second-line immunotherapy's effect was overestimated 26 , 43 . Based on our study, early treatment with anti-inflammatory drugs should be considered to minimize the risk of an unfavourable outcome in cases of CNS inflammatory diseases.…”
Section: Discussionmentioning
confidence: 74%
“…It has been proposed that the underlying mechanism in ANPRA may involve T-cell mediated cytotoxicity. However, there have been only three cases associated with tumors in this context [ 41 ].…”
Section: Discussionmentioning
confidence: 99%